Zobrazeno 1 - 10 of 127 pro vyhledávání: '"Thurecht KJ"'
1
Akademický článek
EGFR Targeting of Liposomal Doxorubicin Improves Recognition and Suppression of Non-Small Cell Lung Cancer
Autor: Moles E, Chang DW, Mansfeld FM, Duly A, Kimpton K, Logan A, Howard CB, Thurecht KJ, Kavallaris M
Publikováno v: International Journal of Nanomedicine, Vol Volume 19, Pp 3623-3639 (2024)
Ernest Moles,1– 4 David W Chang,1– 3 Friederike M Mansfeld,1– 3 Alastair Duly,1,2 Kathleen Kimpton,1 Amy Logan,1– 4 Christopher B Howard,5 Kristofer J Thurecht,5,6 Maria Kavallaris1– 4 1Children’s Cancer Institute, Lowy Cancer Research Ce
Externí odkaz: https://doaj.org/article/b87c3605ba5d4417a67bb7d9cf141e21
Zobrazit plný text záznamu
2
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
3
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
4
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
5
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
9
Akademický článek
A novel immunomodulating peptide with potential to complement oligodeoxynucleotide-mediated adjuvanticity in vaccination strategies.
Autor: Agrez M; InterK Peptide Therapeutics Limited, Lane Cove West, NSW, Australia. michael.agrez@interk.com.au.; Australian Institute for Bioengineering and Nanotechnology and the ARC Training Centre for Innovation in Biomedical Imaging Technologies, University of Queensland, Brisbane, Australia. michael.agrez@interk.com.au., Chandler C; Auspep Pty Limited, Melbourne, Australia., Thurecht KJ; Centre for Advanced Imaging, University of Queensland, Brisbane, Australia.; Australian Institute for Bioengineering and Nanotechnology and the ARC Training Centre for Innovation in Biomedical Imaging Technologies, University of Queensland, Brisbane, Australia., Fletcher NL; Centre for Advanced Imaging, University of Queensland, Brisbane, Australia.; Australian Institute for Bioengineering and Nanotechnology and the ARC Training Centre for Innovation in Biomedical Imaging Technologies, University of Queensland, Brisbane, Australia., Liu F; Centre for Advanced Imaging, University of Queensland, Brisbane, Australia.; Australian Institute for Bioengineering and Nanotechnology and the ARC Training Centre for Innovation in Biomedical Imaging Technologies, University of Queensland, Brisbane, Australia., Subramaniam G; Centre for Advanced Imaging, University of Queensland, Brisbane, Australia.; Australian Institute for Bioengineering and Nanotechnology and the ARC Training Centre for Innovation in Biomedical Imaging Technologies, University of Queensland, Brisbane, Australia., Howard CB; Centre for Advanced Imaging, University of Queensland, Brisbane, Australia.; Australian Institute for Bioengineering and Nanotechnology and the ARC Training Centre for Innovation in Biomedical Imaging Technologies, University of Queensland, Brisbane, Australia., Parker S; InterK Peptide Therapeutics Limited, Lane Cove West, NSW, Australia., Turner D; Concept Life Sciences, Edinburgh, Scotland., Rzepecka J; Concept Life Sciences, Edinburgh, Scotland., Knox G; Concept Life Sciences, Edinburgh, Scotland., Nika A; Concept Life Sciences, Edinburgh, Scotland., Hall AM; Concept Life Sciences, Edinburgh, Scotland., Gooding H; Concept Life Sciences, Edinburgh, Scotland., Gallagher L; Concept Life Sciences, Edinburgh, Scotland.
Publikováno v: Scientific reports [Sci Rep] 2024 Nov 05; Vol. 14 (1), pp. 26737. Date of Electronic Publication: 2024 Nov 05.
Zobrazit plný text záznamu
10
Akademický článek
Patient-Specific Nanoparticle Targeting in Human Leukemia Blood.
Autor: Ju Y; School of Science, RMIT University, Melbourne, Victoria 3000, Australia.; Department of Microbiology and Immunology, Peter Doherty Institute for Infection and Immunity, The University of Melbourne, Melbourne, Victoria 3000, Australia., Li S; School of Science, RMIT University, Melbourne, Victoria 3000, Australia., Tan AEQ; Department of Microbiology and Immunology, Peter Doherty Institute for Infection and Immunity, The University of Melbourne, Melbourne, Victoria 3000, Australia., Pilkington EH; Department of Microbiology and Immunology, Peter Doherty Institute for Infection and Immunity, The University of Melbourne, Melbourne, Victoria 3000, Australia., Brannon PT; Materials Characterisation and Fabrication Platform, The University of Melbourne, Parkville, Victoria 3010, Australia., Plebanski M; School of Health and Biomedical Sciences, RMIT University, Bundoora, Victoria 3083, Australia., Cui J; Key Laboratory of Colloid and Interface Chemistry of the Ministry of Education, School of Chemistry and Chemical Engineering, Shandong University, Jinan, Shandong 250100, China., Caruso F; Department of Chemical Engineering, The University of Melbourne, Parkville, Victoria 3010, Australia., Thurecht KJ; Australian Institute for Bioengineering and Nanotechnology, University of Queensland, St Lucia 4072, Australia., Tam C; Department of Clinical Haematology, The Royal Melbourne Hospital and Peter MacCallum Cancer Centre, Melbourne, Victoria 3000, Australia.; Faculty of Medicine, Dentistry and Health Sciences, The University of Melbourne, Melbourne, Victoria 3000, Australia., Kent SJ; Department of Microbiology and Immunology, Peter Doherty Institute for Infection and Immunity, The University of Melbourne, Melbourne, Victoria 3000, Australia.; Melbourne Sexual Health Centre and Department of Infectious Diseases, Alfred Hospital and Central Clinical School, Monash University, Melbourne, Victoria 3000, Australia.
Publikováno v: ACS nano [ACS Nano] 2024 Oct 22; Vol. 18 (42), pp. 29021-29035. Date of Electronic Publication: 2024 Oct 09.
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje